Betulonicacid
97%
- Product Code: 78782
CAS:
4481-62-3
| Molecular Weight: | 454.69 g./mol | Molecular Formula: | C₃₀H₄₆O₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD08459607 | |
| Melting Point: | Boiling Point: | 548.1°C at 760 mmHg | |
| Density: | Storage Condition: | 2~8℃ |
Product Description:
Betulonic acid is primarily utilized in the field of medicinal chemistry due to its potential therapeutic properties. It has been studied for its anti-inflammatory and anticancer activities, making it a candidate for developing new drugs targeting these conditions. Researchers are exploring its ability to inhibit the growth of cancer cells and reduce inflammation in various models. Additionally, betulonic acid is being investigated for its role in enhancing the efficacy of existing treatments, potentially serving as an adjunct therapy. Its applications extend to the development of novel pharmaceutical formulations aimed at improving patient outcomes in oncology and inflammatory diseases.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to Almost white Crystal or Powder |
| PURITY | 96.5-100 |
| NMR | Conforms to Structure |
| MELTING POINT | 262-266 |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | $120.54 |
+
-
|
| 0.050 | 10-20 days | $361.63 |
+
-
|
| 0.100 | 10-20 days | $683.07 |
+
-
|
Betulonicacid
Betulonic acid is primarily utilized in the field of medicinal chemistry due to its potential therapeutic properties. It has been studied for its anti-inflammatory and anticancer activities, making it a candidate for developing new drugs targeting these conditions. Researchers are exploring its ability to inhibit the growth of cancer cells and reduce inflammation in various models. Additionally, betulonic acid is being investigated for its role in enhancing the efficacy of existing treatments, potentially serving as an adjunct therapy. Its applications extend to the development of novel pharmaceutical formulations aimed at improving patient outcomes in oncology and inflammatory diseases.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :